Columbia Labs Cites Lil’ Drug Store Partnership As Growth Driver
This article was originally published in The Tan Sheet
Executive Summary
Columbia Labs sees continued growth potential in its recently divested OTC women's healthcare lines
You may also be interested in...
Lil’ Drug Store Grows With Acquisition Of Columbia Labs OTCs
Lil' Drug Store will gain access to Columbia Labs' nonprescription women's healthcare products through the acquisition of the firm's OTC portfolio
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands